Methodist Research Institute

Indianapolis, Indiana 46202

0 studies enrolling now · 3 studies all time

What they study most

Sepsis, Septic Shock, Severe Sepsis, Type 1 Diabetes Mellitus

Studies at this site

• Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus — Stopped early
• Protocolized Care for Early Septic Shock — Completed
• Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis — Paused